382 related articles for article (PubMed ID: 2562362)
1. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.
Allain JP; Laurian Y; Paul DA; Verroust F; Leuther M; Gazengel C; Senn D; Larrieu MJ; Bosser C
N Engl J Med; 1987 Oct; 317(18):1114-21. PubMed ID: 3477695
[TBL] [Abstract][Full Text] [Related]
8. Plasma viremia in human immunodeficiency virus infection.
Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
[TBL] [Abstract][Full Text] [Related]
10. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
[TBL] [Abstract][Full Text] [Related]
13. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
Forster SM; Osborne LM; Cheingsong-Popov R; Kenny C; Burnell R; Jeffries DJ; Pinching AJ; Harris JR; Weber JN
AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
[TBL] [Abstract][Full Text] [Related]
14. [HIV serological parameters in the prognosis and follow-up assessment of an HIV infection].
Grob PJ; Joller-Jemelka H; Lüthy R; Täuber M; Ledergerber B; Brühwiler J; Fierz W
Schweiz Med Wochenschr; 1988 Jan; 118(2):58-64. PubMed ID: 3422761
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
16. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
18. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
20. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
Pincus SH; Messer KG; Nara PL; Blattner WA; Colclough G; Reitz M
J Clin Invest; 1994 Jun; 93(6):2505-13. PubMed ID: 7515393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]